SpringWorks Therapeutics Inc (NAS:SWTX)
$ 41.48 -0.25 (-0.6%) Market Cap: 3.09 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 5.79 GF Score: 38/100

SpringWorks Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 06:20PM GMT
Release Date Price: $25.48 (+8.01%)
Alec Stranahan
Bank of America - VP, Equity Research

Hey, everyone. Good morning and welcome to day one of the B of A Healthcare Conference. Thanks for joining this session with SpringWorks Therapeutics. My name is Alec Stranahan. I'm Vice President and Senior Biotech Analyst covering SpringWorks here at B of A. And I'm pleased to be joined by Saqib Islam, Chief Executive Officer of SpringWorks, and Badreddin Edris, Chief Operating Officer of SpringWorks. Thanks for being here, guys.

Saqib Islam
SpringWorks Therapeutics, Inc. - CEO

Thanks for having us. Great.

Alec Stranahan
Bank of America - VP, Equity Research

Great. So I believe Saqib is going to run through some prepared remarks to start, and then we'll jump into Q&A. So over to you.

Saqib Islam
SpringWorks Therapeutics, Inc. - CEO

Yeah. I mean, relatively minimal prepared remarks, but I'd just say that kind of we are in a very interesting moment. Let's put aside the sector and whatever's going on. Broadly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot